As a critical component of metabolic syndrome, obesity contributes to the progression of RA through various mechanisms.[5–7] Specifically, it promotes systemic inflammation and immune dysfunction by activating pro-inflammatory cytokines, including tumor necrosis factor-α, interleukin-6, and interleukin-1β. This evidence concerns the gene IL6 and obesity due to melanocortin 4 receptor deficiency.